View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Carole Braudeau
  • Carole Braudeau

Credit Morning 11/20/2024

Grifols: the board considers that Brookfield’s indicative price undervalues the company Teva: S&P upgrades the rating to BB/positive from BB/positiveElior: Results recovered in 2023-24, exceeding expectations. Debt reduction is making headway as planned.Tereos: Sharp decline in EBITDA in Q2 24/25. The financial position is stable thanks to the generation of FCF.>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 20/11/2024

Grifols : le conseil d’administration estime que le prix indicatif proposé par Brookfield sous-évalue la sociétéTeva: S&P upgrades the rating to BB/positive from BB/positiveElior: les résultats se sont redressés 2023/24, dépassant les attentes. Le désendettement progresse comme prévu.Tereos : fort repli de l'EBITDA au T2 24/25. La situation financière est stable grâce à la génération de FCF.>...

Juan Ros-Padilla
  • Juan Ros-Padilla

Grifols A : Brookfield confirms a non-binding indication of € 10.50. G...

>Brookfield confirms that it has issued a non-binding indication of € 10.5 - Brookfield unveiled, via a regulatory filing, that it recently requested more information from Grifols’ Transaction Committee with which to finalise its due diligence and issued a non-binding price indication of € 10.50 per class A share and € 7.62 per class B share. Brookfield added that it continues to engage constructively with Grifols yet, for the time being, no agreement or decision has...

Luis Arredondo
  • Luis Arredondo

GRIFOLS: BROOKFIELD CONFIRMA QUE BARAJA UNA OFERTA A 10,5 EUROS/ACC. P...

El fondo Brookfield acaba de confirmar que trasladó el 11 de noviembre al Comité de Transacción de GRF que estaba considerando (como valor no vinculante) un precio de 10,5 euros/acc.

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/18/2024

Grifols : Brookfield mulls a possible offer price of € 10.5 (El Confidencial)>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 18/11/2024

Grifols : Brookfield envisagerait un éventuel prix d’offre de 10,5 EUR/action (El Confidencial)>...

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/15/2024

Rekeep: Q3 2024 results. Debt increased again as a result of the increase in working capital and a reassessment of the value of the put on Rekeep Polska. Altice France: no agreement between the company and secured creditors but proposals are getting closer>...

Carole Braudeau
  • Carole Braudeau

Morning Crédit 15/11/2024

Rekeep : Résultats T3 24. L’endettement est reparti à la hausse, avec le rebond du BFR et après une réestimation de la valeur du put sur Rekeep Polska.Altice France : pas d’accord entre la société et les créanciers secured mais les positions se rapprochent>...

Stephane Beyazian
  • Stephane Beyazian

Vodafone : Better FCF in H1 2025 but record low in Germany

>H1 2025 EBITDA in line with expectations - Q2 2025 group sales were up 4.6% y-o-y to € 9,240m, above expectations (consensus € 9,071m, ODDO BHF € 9,226m), and still helped by hyperinflation in Turkey (sales +89% y-o-y). H1 2025 EBITDAaL was up 2.5% y-o-y to € 2,730m. The targets for 2025 were confirmed (as expected): Vodafone is targeting adjusted pro forma EBITDAaL of € 11bn and adjusted FCF of at least € 2.4bn (consensus: € 2.47bn). These pro forma targets are...

Stephane Beyazian
  • Stephane Beyazian

Vodafone : Better FCF in H1 2025 but record low in Germany

>H1 2025 EBITDA in line with expectations - Q2 2025 group sales were up 4.6% y-o-y to € 9,240m, above expectations (consensus € 9,071m, ODDO BHF € 9,226m), and still helped by hyperinflation in Turkey (sales +89% y-o-y). H1 2025 EBITDAaL was up 2.5% y-o-y to € 2,730m. The targets for 2025 were confirmed (as expected): Vodafone is targeting adjusted pro forma EBITDAaL of € 11bn and adjusted FCF of at least € 2.4bn (consensus: € 2.47bn). These pro forma targets are...

Chris Hoare
  • Chris Hoare

Vodacom (Buy, TP: ZAR150, +50%) Q2 25: Soft vs. expectations

Vodacom has reported a soft set of Q2 results relative to expectations. However, trends remained solid, especially top line which continued to grow close to double digit growth. This is encouraging and we continue to think that the tide is turning in SA (please see HERE for more details), but it seems the turn will take longer than we hoped.

 PRESS RELEASE

Informations sur les droits de vote et les actions au 31 octobre 2024

Informations sur les droits de vote et les actions au 31 octobre 2024 Le 8 novembre 2024 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social   Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation :        Euronext ParisCompartiment :        Compartiment ACode ISIN :                FR0000054470Site web :                 Date Nombre total d’actions composant le capital social Nombre total de droits de vote Total brut (1) Total net (2) 31/10/2024 130 714 789 143 008 225 143 008 22...

Carole Braudeau
  • Carole Braudeau

Credit Morning 11/08/2024

Altarea: Q3 still weak, but positive messages for year-end Maxeda: Moody’s has downgraded the corporate rating to Caa1/negative>...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch